Lifting the Mood on Treating Fragile X
Only a decade ago, it was believed that a genetic diagnosis of intellectual disability and autism offered little in the way of hope for a medical treatment to lessen the burden on the affected individuals and their families. However, recent research aimed at understanding the cellular and molecular...
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
Elsevier
2016
|
| Online Access: | http://hdl.handle.net/1721.1/102434 https://orcid.org/0000-0003-0582-2284 |
| _version_ | 1826189129937846272 |
|---|---|
| author | Kind, Peter C. Osterweil, Emily Bear, Mark |
| author2 | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences |
| author_facet | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences Kind, Peter C. Osterweil, Emily Bear, Mark |
| author_sort | Kind, Peter C. |
| collection | MIT |
| description | Only a decade ago, it was believed that a genetic diagnosis of intellectual disability and autism offered little in the way of hope for a medical treatment to lessen the burden on the affected individuals and their families. However, recent research aimed at understanding the cellular and molecular mechanisms that underlie the pathogenesis of ASD has ushered in a new era of targeted treatment strategies. Studies in fragile X syndrome (FXS) have been at the forefront of this revolution, and they are forging a path that could define future approaches to the treatment of ASD. |
| first_indexed | 2024-09-23T08:10:18Z |
| format | Article |
| id | mit-1721.1/102434 |
| institution | Massachusetts Institute of Technology |
| language | en_US |
| last_indexed | 2024-09-23T08:10:18Z |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | mit-1721.1/1024342022-09-23T11:23:07Z Lifting the Mood on Treating Fragile X Kind, Peter C. Osterweil, Emily Bear, Mark Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences Picower Institute for Learning and Memory Bear, Mark Osterweil, Emily Bear, Mark Only a decade ago, it was believed that a genetic diagnosis of intellectual disability and autism offered little in the way of hope for a medical treatment to lessen the burden on the affected individuals and their families. However, recent research aimed at understanding the cellular and molecular mechanisms that underlie the pathogenesis of ASD has ushered in a new era of targeted treatment strategies. Studies in fragile X syndrome (FXS) have been at the forefront of this revolution, and they are forging a path that could define future approaches to the treatment of ASD. 2016-05-09T16:15:01Z 2016-05-09T16:15:01Z 2012-11 2012-09 Article http://purl.org/eprint/type/JournalArticle 00063223 http://hdl.handle.net/1721.1/102434 Osterweil, Emily K., Peter C. Kind, and Mark F. Bear. “Lifting the Mood on Treating Fragile X.” Biological Psychiatry 72, no. 11 (December 2012): 895–97. https://orcid.org/0000-0003-0582-2284 en_US http://dx.doi.org/10.1016/j.biopsych.2012.09.017 Biological Psychiatry Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Elsevier Prof. Bear |
| spellingShingle | Kind, Peter C. Osterweil, Emily Bear, Mark Lifting the Mood on Treating Fragile X |
| title | Lifting the Mood on Treating Fragile X |
| title_full | Lifting the Mood on Treating Fragile X |
| title_fullStr | Lifting the Mood on Treating Fragile X |
| title_full_unstemmed | Lifting the Mood on Treating Fragile X |
| title_short | Lifting the Mood on Treating Fragile X |
| title_sort | lifting the mood on treating fragile x |
| url | http://hdl.handle.net/1721.1/102434 https://orcid.org/0000-0003-0582-2284 |
| work_keys_str_mv | AT kindpeterc liftingthemoodontreatingfragilex AT osterweilemily liftingthemoodontreatingfragilex AT bearmark liftingthemoodontreatingfragilex |